A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Conditions: Type 2 Diabetes Interventions: Drug: Cagrilintide; Drug: Semaglutide; Drug: Placebo Sponsors: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Type 2 | Diets | Endocrinology | Nutrition | Research | Sports Medicine | Study | Sugar